Peteris Alberts
R&d
Riga, RIX, Latvia
Riga, RIX, Latvia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir.
Journal: The Permanente journal
Published: August 11, 2022
Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir® Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525.
Journal: Viruses
Published: March 15, 2022
Oncolytic virus preclinical toxicology studies.
Journal: Journal of applied toxicology : JAT
Published: March 02, 2022
4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir administered intramuscularly with a 4-week recovery period.
Journal: Toxicology reports
Published: September 03, 2020
Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir® therapy: A case report.
Journal: Clinical case reports
Published: January 29, 2020
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines.
Journal: BMC research notes
Published: January 21, 2020
Comment on: Malfitano, A.M. et al. "Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer" Cancers 2019, 11, 1532.
Journal: Cancers
Published: December 02, 2019
A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report.
Journal: SAGE open medical case reports
Published: October 27, 2019
ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report.
Journal: American journal of ophthalmology case reports
Published: June 28, 2019
Last Updated: 09/26/2026